TECTONIC THERAPEUTIC, INC. Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year
TECTONIC THERAPEUTIC, INC. (TECX) had Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year of $769.00 thousand as of 2024-06-30, per its 10-Q filed 2024-08-14.
Discontinued › Notes › Leases
us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear · last filed 2024-08-14
- 2024-06-30: Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year $769.00K.
- 2024-03-31: Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year $224.00K.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year |
|---|---|
| 2024-06-30 | $769.00K 10-Q · filed 2024-08-14 |
| 2024-03-31 | $224.00K 10-Q · filed 2024-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |